Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
MiNK Therapeutics (INKT)
NASDAQ:INKT
MiNK Therapeutics (INKT) Ownership - Who Owns MiNK Therapeutics?
88 Followers
MiNK Therapeutics (INKT) Ownership Overview
71.57% Insiders
1.26% Mutual Funds
0.71% Other Institutional Investors
26.46% Public Companies and
Individual Investors
The ownership structure of MiNK Therapeutics (INKT) stock is a mix of institutional, retail and individual investors. Approximately 1.97% of the company’s stock is owned by Institutional Investors, 71.57% is owned by Insiders and 26.46% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 16, 2023 | Agenus Inc >10% Owner | Bought | $25236 |
| Oct 06, 2023 | Agenus Inc >10% Owner | Bought | $16351 |
| Aug 31, 2023 | Agenus Inc >10% Owner | Bought | $44814 |
| Aug 28, 2023 | Agenus Inc >10% Owner | Bought | $280619 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 234,182 | Institution | 0.67% | 205,143 | |
| 234,182 | Institution | 0.67% | 205,143 | |
| 89,433 | Institution | 0.26% | 78,343 | |
| 38,713 | Institution | 0.11% | 33,913 | |
| 36,898 | Institution | 0.11% | 32,323 | |
| 27,384 | Institution | 0.08% | 23,988 | |
| 13,954 | Institution | 0.04% | 12,224 | |
| 11,952 | Institution | 0.03% | 10,470 | |
| 10,699 | Institution | 0.03% | 9,372 | |
| 8,500 | Institution | 0.02% | 7,446 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 234,182 | Institution | 0.67% | 205,143 | |
| 89,433 | Institution | 0.26% | 78,343 | |
| 38,713 | Institution | 0.11% | 33,913 | |
| 27,384 | Institution | 0.08% | 23,988 | |
| 13,954 | Institution | 0.04% | 12,224 | |
| 11,952 | Institution | 0.03% | 10,470 | |
| 8,500 | Institution | 0.02% | 7,446 | |
| 3,871 | Institution | 0.01% | 3,391 | |
| 2,783 | Institution | <0.01% | 2,438 | |
| 2,650 | Institution | <0.01% | 2,321 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 148,229 | Institution | 0.43% | 134,636 | |
| 85,953 | Institution | 0.25% | 78,071 | |
| 10,699 | Institution | 0.03% | 9,376 |
FAQ
Who Owns MiNK Therapeutics (INKT)?
According to the latest TipRanks data, approximately 0.71% of the company's stock is held by institutional investors, 71.57% is held by insiders, and 26.46% is held by retail investors.
What percentage of MiNK Therapeutics (INKT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.71% of MiNK Therapeutics (INKT) stock is held by institutional investors.
What percentage of MiNK Therapeutics (INKT) stock is held by retail investors?
According to the latest TipRanks data, approximately 26.46% of MiNK Therapeutics (INKT) stock is held by retail investors.
Who owns the most shares of MiNK Therapeutics (INKT)?
Vanguard owns the most shares of MiNK Therapeutics (INKT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.